Tandem Diabetes Care Files 2025 Proxy Statement
Ticker: TNDM · Form: DEF 14A · Filed: Apr 8, 2025 · CIK: 1438133
| Field | Detail |
|---|---|
| Company | Tandem Diabetes Care Inc (TNDM) |
| Form Type | DEF 14A |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: TNDM
TL;DR
Tandem Diabetes Care (TNDM) proxy filing out. Details exec pay & board for FY24.
AI Summary
Tandem Diabetes Care Inc. filed its DEF 14A proxy statement on April 8, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, board of directors, and other corporate governance matters. Key financial data for the years 2020 through 2024 is included, providing a historical overview of the company's performance.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and corporate governance, enabling informed voting decisions on important company matters.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal changes in executive compensation or governance that may impact investor confidence and stock performance.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the proxy statement.)
- 20250408 — Filing Date (Date the DEF 14A was filed with the SEC.)
Key Players & Entities
- TANDEM DIABETES CARE INC (company) — Filer
- San Diego (location) — Business Address City
- DE (location) — State of Incorporation
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit proxies from shareholders for an upcoming annual or special meeting of shareholders. It provides detailed information about matters to be voted on, such as the election of directors, executive compensation, and other corporate actions.
When is the fiscal year end for Tandem Diabetes Care Inc. as reported in this filing?
The fiscal year end for Tandem Diabetes Care Inc. is December 31, as indicated by the 'CONFORMED PERIOD OF REPORT: 20241231'.
What is the filing date of this DEF 14A statement?
This DEF 14A statement was filed on April 8, 2025, as indicated by 'FILED AS OF DATE: 20250408'.
Where is Tandem Diabetes Care Inc. headquartered?
Tandem Diabetes Care Inc. is headquartered in San Diego, California, with its business and mail address listed as 12400 High Bluff Drive, San Diego, CA 92130.
What is the SIC code for Tandem Diabetes Care Inc.?
The Standard Industrial Classification (SIC) code for Tandem Diabetes Care Inc. is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 8, 2025 regarding TANDEM DIABETES CARE INC (TNDM).